$heff's $tation of $tocks & $olid DD

[beach_trades]

CYTK-4 Buy ratings past month

Cytokinetics Stock Rating Reaffirmed by Canaccord Genuity (CYTK)

http://www.jagsreport.com/2012/08/cytokinetics-stock-rating-reaffirmed-by-canaccord-genuity-cytk/

Canaccord Genuity reiterated their buy rating on shares of Cytokinetics (NASDAQ: CYTK) in a research note issued to investors on Wednesday.

CYTK has been the subject of a number of other recent research reports. Analysts at Cowen initiated coverage on shares of Cytokinetics in a research note to investors on Wednesday. They set an outperform rating on the stock.

Separately, analysts at Rodman & Renshaw reiterated an outperform rating on shares of Cytokinetics in a research note to investors on Tuesday. They now have a $2.00 price target on the stock.

Finally, analysts at Needham & Company initiated coverage on shares of Cytokinetics in a research note to investors on Monday, July 2nd. They set a buy rating and a $2.50 price target on the stock.